Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
07/2006
07/26/2006CN1809545A N-phenyl-piperazine derivatives and methods of prophylaxis or treatment of 5HT2c
07/26/2006CN1807394A Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof
07/26/2006CN1266118C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
07/26/2006CN1266112C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
07/25/2006US7081535 omega-carboxy-2-hydroxy- ethyl- or propyl-amines, 1-substituted with thienyl, phenyl, pyridyl, allyl or propargyl; used in synthesis of pharmaceuticals
07/25/2006US7081459 1-substituted pyridine-2-ones or 2-substituted pyridazin-3-ones; anticarcinogenic agents for breast and prostate cancer; contraceptives; endometriosis, benign prostatic hypertophy
07/25/2006US7081458 Small molecule, non-peptide antagonists; antidiabetic agents; obesity; {5-[1-4-Methoxy-2,3-dimethyl-phenyl)-ethyl]-(1S,4S)-2,5-diaza-bicyclo[2.2.1]hept-2-yl}-(4-trifluoromethyl-phenyl)-methanone
07/25/2006CA2283663C Benzocycloheptathiophene compounds
07/20/2006WO2006074957A1 Substituted aminomethylene sulphonamides, production and use thereof as medicaments
07/20/2006WO2006074924A1 3,4,(5)-substituted tetrahvdropyridines
07/20/2006WO2006026532A3 Methods of treatment of amyloidosis using substituted ethanolcyclicamine aspartyl protease inhibitors
07/20/2006WO2006015338A3 Crystalline form of donepezil hydrochloride
07/20/2006US20060161006 Asymmetric urea compound and process for producing asymmetric compound by asymmetric conjugate addition reaction with the same as catalyst
07/20/2006US20060160862 Caspase inhibitors and uses thereof
07/20/2006US20060160851 Substituted piperidine carbamates
07/20/2006US20060160825 1-(5-Benzenesulfonyl-indan-1-yl)-piperazine, used as selective serotonin receptor antagonists for treatment of nervous system and gastrointestinal disorders
07/20/2006US20060160788 such as Rac-(2-isopropoxy-5-methanesulfonyl-phenyl)-[3-(4-trifluoromethyl-phenoxy)-pyrrolidin-1-yl]-methanone, having good glycine transporter inhibitory activity and useful for the treatment of nervous system disorders such as schizophrenia, cognitive impairment and Alzheimer's disease
07/20/2006US20060159617 Small technetium-99m and rhenium labeled agents and methods for imaging tissues, organs and tumors
07/20/2006CA2601343A1 Substituted aminomethylene sulphonamides, production and use thereof as medicaments
07/20/2006CA2590898A1 3,4,(5)-substituted tetrahvdropyridines
07/19/2006EP1680406A1 N-substituted benzene sulfonamides
07/19/2006EP1680403A1 Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors
07/19/2006EP1680395A2 Novel ligand activating receptors rars used for human medicine and cosmetics
07/19/2006EP1680113A2 Dopamine-, norepinephrine- and serotonin- transporter- selective heterocyclic compounds and their therapeutic applications
07/19/2006EP1680109A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
07/19/2006EP1532124B1 Use of nitrile derivatives as medicament.
07/19/2006EP1395575B1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
07/19/2006CN1805951A Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase
07/19/2006CN1805944A Cyclic hydroxylamine as psychoactive compounds
07/19/2006CN1805935A Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic M3 receptor
07/19/2006CN1805934A 2-hydroxymethyl-3,4,5-trihydroxy-1-(4-pentlyoxybenzyl)piperidine as glucosylceramide synthase (GCS) inhibitor
07/19/2006CN1805933A 2-hydroxymethyl-3,4,5-trihydroxy-1benzylpiperidine derivatives as inhibitors of glucosylceramide synthase (gcs)
07/19/2006CN1805927A 1- (alkylaminoalkyl-pyrolidin-/piperidinyl) -2, 2-diphenylacetamide derivatives as muscarinic receptor antagonists
07/19/2006CN1805915A Indene derivatives as pharmaceutical agents
07/19/2006CN1805747A 4-(4-(heterocyclylalkoxy phenyl)-1-(heterocyclyl-carbonyl)piperidine derivatives and related compounds as histamine h3 antagonists for the treatment of neurological diseases such as alzheimer's
07/19/2006CN1264828C Nitric ester and nitrate salts of specific drugs
07/19/2006CN1264821C Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
07/18/2006USRE39198 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgesics
07/18/2006USRE39197 diaryl sulfides, substituted with cinnamides, such as (2,4-Dichlorophenyl)[2-(E-((6-hydroxyhexylamino)carbonyl)ethenyl)phenyl]sulfide, used for treating inflammatory and immune diseases in mammals
07/18/2006US7078567 Forming c-n bonds; isomerization
07/18/2006US7078537 Phenylalkyl diamine and amide analogs
07/18/2006US7078424 Central nervous system disorders; alopecia
07/18/2006US7078415 1-(omego-substituted-2-[(hetero)arylcarbonylamino]alkanoyl)-4-(1-methylpiperidin-4-yl)piperidine derivatives; e.g., 1-[N-(Indole-6-carbonyl)-D-serinyl]-4-(1-methylpiperidin-4-yl)piperidine Hydrochloride
07/18/2006US7078401 "PGI2-preferring" (IP) receptors; p-(imidazolin-2-ylamino-optional alkyl)phenyl p'-substituted ethers or sulfides, e.g., 4,5-Dihydro-1H-imidazol-2-yl)-[4-(4-isopropoxy-phenylsulfanyl)-phenyl]-amine, used to induce hyperalgesia
07/18/2006CA2356320C Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
07/18/2006CA2214288C Process for the preparation of 1-acyl-4-arylpiperidines
07/13/2006WO2006074270A2 Synthesis of ccr5 receptor antagonists
07/13/2006WO2006073967A1 Piperidine derivatives as prodrugs of potassium channel inhibitors
07/13/2006WO2006072785A2 Base stable ionic liquids
07/13/2006WO2006072432A1 Benzoyl-tetrahydropyridine as glyt-1 inhibitors
07/13/2006WO2006031764A3 Processes for prepating n-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and intermediates
07/13/2006WO2006002088A3 Amino-quinazoline derivatives as antitumor agents
07/13/2006WO2005112945A3 Synthesis of tetracyclines and analogues thereof
07/13/2006US20060155140 Blends of quinone alkide and nitroxyl compounds as polymerization inhibitors
07/13/2006US20060154988 intracellular inhibition of bacterial polypeptide deformylase in gramnegative bacteria,
07/13/2006US20060154964 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
07/13/2006US20060154933 Inhibitors of Cdc25 phosphatases
07/13/2006US20060154922 Muscarinic agonists
07/13/2006US20060154912 Isophtalic acid derivatives
07/13/2006US20060154872 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting
07/13/2006CA2594260A1 Benzoyl-tetrahydropyridine as glyt-1 inhibitors
07/13/2006CA2594114A1 Synthesis of ccr5 receptor antagonists
07/13/2006CA2587195A1 Cycloalkyl keto piperidine tachykinin receptor antagonists
07/12/2006EP1679069A1 Novel piperidine derivative
07/12/2006EP1678167A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
07/12/2006EP1678154A1 Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use
07/12/2006EP1441718B1 Use of carbinols for the treatment of neuropathic dysfunction
07/12/2006CN1802159A 2-phenoxy- and 2-phenylsulfomamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
07/12/2006CN1802155A Neurocyte protective agent
07/12/2006CN1800185A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes.
07/12/2006CN1263753C Method for synthetizing orixine and RU-19110 intermediate
07/12/2006CN1263740C Pot cooking sythesis method of alipyracole
07/12/2006CN1263739C Carboxypeptidase U suppressed compound and its preparation method, pharmaceutical composition containing the compound and its uses
07/12/2006CN1263731C Novel immunotherapeutic agents and their use in production of cytokine levels
07/12/2006CN1263720C Triphenylalkene derivatives and their use as selective estrogen receptor modulators
07/11/2006US7074936 Analyzing hydrophobic proteins; laser desorption ionization spectroscopy
07/11/2006US7074935 Multistage process with acylation of amine as anesthetics
07/11/2006US7074934 Serine protease inhibitors
07/11/2006US7074931 Reacting a 1,3-cyclohexanedione with a homo-chiral phenylethylamine, reacting assymmetric vinlogous amide with alpha-beta-unsaturated ketone in presence of a silicon compound to form asymmetric diketone, then dihydropyridine
07/11/2006US7074831 Autoimmune diseases; antiinflammatory agents; graft versus host disease; anticancer agents; antiarthritic agents
07/11/2006US7074808 4-(Phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestional disorders
07/11/2006US7074807 Compositions and methods for inducing cell death
07/11/2006US7074803 Fentanyl, or compound thereof; reducing pain
07/11/2006US7074795 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
07/11/2006US7074786 Histogranin-like peptides, processes for their preparation and uses thereof
07/11/2006US7074780 Substituted phenylcyclohexanecarboxamides and their use
07/11/2006CA2364718C Monoamine reuptake inhibitors for treatment of cns disorders
07/11/2006CA2274074C Novel compounds with analgesic effect
07/11/2006CA2206532C Novel amidinonaphthyl derivative or salt thereof
07/06/2006WO2006071750A1 4-piperidinol tertiary amines as histamine 3 receptor inhibitors for the treatment of obesity and other cns disorders
07/06/2006WO2006070878A1 Carboxylic acid derivative or salt thereof
07/06/2006WO2006070396A1 Process for producing 1-benzyl-4-[(5,6-dimethoxy-1-indanon­2-yl)methyl] piperidine or its salt thereof via novel intermediate
07/06/2006WO2006069788A1 Organic compounds
07/06/2006WO2006069678A1 Conjugates of metal complex hydroxypyridin derivatives and biomolecules and the use thereof for producing agents used in nmr diagnosis
07/06/2006WO2006069676A1 Hydroxypyridinone derivatives, their metal complexes and their use in the production of conjugates with biomolecules
07/06/2006US20060149092 Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease
07/06/2006US20060149071 Hydrolyzing the ester group of an alkylated 4-amino-4-carboxyamino-piperidine compound and treating the piperidine hydrolysis product with a hydride to produce a 4-hydroxymethyl-piperidine; method requires fewer steps and produces a greater yield of product than known methods; synthetic opioids
07/06/2006US20060149070 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
07/06/2006US20060148852 Visual function disorder improving agents
07/06/2006US20060148851 Fexofenadine crystal form and processes for its preparation thereof